Skip to main content
Top
Published in: Critical Care 1/2002

01-02-2002 | Meeting abstract

Terlipressin in the treatment of catecholamine resistant septic shock

Authors: GM Auzinger, PG O'Callaghan, RA Harry, JA Wendon

Published in: Critical Care | Special Issue 1/2002

Login to get access

Excerpt

Vasopressin plasma levels are low in advanced septic shock and treatment with low dose vasopressin can reverse catecholamine resistance [1]. Terlipressin, a vasopressin analogue with long half life time, was found to exert less gastrointestinal and myocardial side effects in patients with acute variceal hemorrhage compared with vasopressin. Little is known about effects and side effects of terlipressin administration in patients with septic shock. …
Literature
1.
go back to reference Landry DW, Levin HR, Gallant EM, et al.: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997, 95: 1122-1125.CrossRefPubMed Landry DW, Levin HR, Gallant EM, et al.: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997, 95: 1122-1125.CrossRefPubMed
Metadata
Title
Terlipressin in the treatment of catecholamine resistant septic shock
Authors
GM Auzinger
PG O'Callaghan
RA Harry
JA Wendon
Publication date
01-02-2002
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2002
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1587

Other articles of this Special Issue 1/2002

Critical Care 1/2002 Go to the issue